In the latest session, Alignment Healthcare Inc (NASDAQ: ALHC) closed at $11.86 up 0.85% from its previous closing price of $11.76. In other words, the price has increased by $0.85 from its previous closing price. On the day, 2.6 million shares were traded. ALHC stock price reached its highest trading level at $12.04 during the session, while it also had its lowest trading level at $11.66.
Ratios:
For a deeper understanding of Alignment Healthcare Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 3.05 whereas as Long-Term Debt/Eq ratio is at 3.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 14 ’25 when Maroney Dawn Christine sold 30,000 shares for $13.44 per share. The transaction valued at 403,347 led to the insider holds 2,042,899 shares of the business.
KAO JOHN E sold 180,000 shares of ALHC for $2,413,800 on Jul 10 ’25. The Chief Executive Officer now owns 1,553,100 shares after completing the transaction at $13.41 per share. On Jun 16 ’25, another insider, KAO JOHN E, who serves as the Chief Executive Officer of the company, sold 90,000 shares for $14.48 each. As a result, the insider received 1,302,849 and left with 1,733,100 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2346417920 and an Enterprise Value of 2197245184. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.78 while its Price-to-Book (P/B) ratio in mrq is 21.68. Its current Enterprise Value per Revenue stands at 0.732 whereas that against EBITDA is -64.787.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.13, which has changed by 0.35388124 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $7.92. The 50-Day Moving Average of the stock is -15.99%, while the 200-Day Moving Average is calculated to be -16.31%.
Shares Statistics:
For the past three months, ALHC has traded an average of 3.31M shares per day and 2734530 over the past ten days. A total of 197.67M shares are outstanding, with a floating share count of 131.29M. Insiders hold about 33.64% of the company’s shares, while institutions hold 65.33% stake in the company. Shares short for ALHC as of 1752537600 were 13268490 with a Short Ratio of 4.01, compared to 1749772800 on 10130059. Therefore, it implies a Short% of Shares Outstanding of 13268490 and a Short% of Float of 10.34.
